SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo cuts Rapport Therapeutics target to $47 from $50

Valid market news retained in the public archive without immediate LiveCast distribution.

RAPP

Related stories